4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics
November 16, 2022 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics 16 November 2022 London & New York – 4BIO Capital (“4BIO” or “the Group”), an international...
4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A
March 25, 2020 07:03 ET
|
4Bio Capital
Press Release 4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A Pioneering chemogenetics company is one of the first investments from 4BIO Capital’s Ventures II fund 25 March 2020 ...